Related references
Note: Only part of the references are listed.The Engagement Between MDSCs and Metastases: Partners in Crime
Rosalinda Trovato et al.
FRONTIERS IN ONCOLOGY (2020)
Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim et al.
IMMUNE NETWORK (2020)
Cancer immunotherapy for metastasis: past, present and future
Xiaobo Wang et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy
Hathaichanok Phuengkham et al.
ADVANCED MATERIALS (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy
Sun-Young Kim et al.
ACS NANO (2019)
Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
Jing Zhao et al.
FRONTIERS IN PHARMACOLOGY (2019)
Molecular Repolarisation of Tumour-Associated Macrophages
Floris J. van Dalen et al.
MOLECULES (2019)
Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets
Nikoleta Bizymi et al.
HEMASPHERE (2019)
Fates of CD8+ T cells in Tumor Microenvironment
Nomathamsanqa Resegofetse Maimela et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Combination immunotherapy: Taking Cancer vaccines to the next Level
Jeremy M. Grenier et al.
FRONTIERS IN IMMUNOLOGY (2018)
Factors influencing the Differentiation of human Monocytic Myeloid-Derived suppressor cells into inflammatory Macrophages
Defne Bayik et al.
FRONTIERS IN IMMUNOLOGY (2018)
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells
Fernando P. Canale et al.
CANCER RESEARCH (2018)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy
Lien Lybaert et al.
ADVANCED SCIENCE (2017)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Thomas Condamine et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Macrophage silica nanoparticle response is phenotypically dependent
Heather L. Herd et al.
BIOMATERIALS (2015)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Effect of TLR Agonists on the Differentiation and Function of Human Monocytic Myeloid-Derived Suppressor Cells
Jing Wang et al.
JOURNAL OF IMMUNOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
T-cell exhaustion in the tumor microenvironment
Y. Jiang et al.
CELL DEATH & DISEASE (2015)
Whole Tumor Antigen Vaccines: Where Are We?
Cheryl Lai-Lai Chiang et al.
VACCINES (2015)
Tumor lysate-loaded biodegradable microparticles as cancer vaccines
Vijaya B. Joshi et al.
EXPERT REVIEW OF VACCINES (2014)
The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2014)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Whole Cell Vaccines-Past Progress and Future Strategies
Bridget P. Keenan et al.
SEMINARS IN ONCOLOGY (2012)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Antigens for cancer immunotherapy
Michelle A. Neller et al.
SEMINARS IN IMMUNOLOGY (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Share Paper
